首页>
外国专利>
COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE
COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE
展开▼
机译:结合光动力疗法和抗VEGF剂治疗不想要的脉络膜新血管生成
展开▼
页面导航
摘要
著录项
相似文献
摘要
Treatment of a condition characterized by unwanted choroidal neovascularization is described using a combination of photodynamic therapy and an anti-VEFG agent. These conditions include age-related macular degeneration. Preferred anti-VEGF agents include antibodies such as bevacizumab or ranibizumab. The photosensitizer can be selected from green porphyrins such as BPD-MA (berteppin) and can achieve photodynamic activation of the photosensitizer with low fluence. Additional anti-inflammatory agents such as dexamethasone may also be used.
展开▼